106 related articles for article (PubMed ID: 2716924)
1. Circulating immune complexes (CIC) in Hodgkin's disease. I. Levels and two-dimensional analysis.
Nerurkar AV; Advani SH; Gothoskar BP
Neoplasma; 1989; 36(2):199-205. PubMed ID: 2716924
[TBL] [Abstract][Full Text] [Related]
2. Circulating immune complexes in Hodgkin's disease.
Akolkar PN; Advani SH; Gothoskar BP
Neoplasma; 1983; 30(1):73-9. PubMed ID: 6835441
[TBL] [Abstract][Full Text] [Related]
3. Influence of splenectomy on the levels of circulating immune complexes (CIC) in Hodgkin's disease (HD).
Nerurkar AV; Advani SH; Gothoskar BP
Neoplasma; 1987; 34(1):89-93. PubMed ID: 3561608
[TBL] [Abstract][Full Text] [Related]
4. Circulating immune complexes in Hodgkin's disease. Reactivity of IgG isolated from circulating immune complexes.
Nerurkar AV; Advani SH; Gothoskar BP
Neoplasma; 1993; 40(2):87-91. PubMed ID: 8350960
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
Tomasević Z; Jelić S
Arch Immunol Ther Exp (Warsz); 2000; 48(3):195-200. PubMed ID: 10912625
[TBL] [Abstract][Full Text] [Related]
6. Circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease. Their relationship to immune function.
Spinozzi F; Velardi A; Rambotti P; Losito A; Zampi I; Cernetti C; Gerli R; Martelli MF; Grignani F
J Clin Lab Immunol; 1983 Oct; 12(2):87-92. PubMed ID: 6644793
[TBL] [Abstract][Full Text] [Related]
7. Significance of breast carcinoma-associated antigens as a monitor of tumor burden: characterization by monoclonal antibodies.
Salinas FA; Wee KH; Ceriani RL
Cancer Res; 1987 Feb; 47(3):907-13. PubMed ID: 3802085
[TBL] [Abstract][Full Text] [Related]
8. The presence and structure of circulating immune complexes in patients with prostate tumors.
Gołda R; Wolski Z; Wyszomirska-Gołda M; Madaliński K; Michałkiewicz J
Med Sci Monit; 2004 Mar; 10(3):CR123-7. PubMed ID: 14976452
[TBL] [Abstract][Full Text] [Related]
9. [Circulating immune complexes in the serum in Hodgkin's disease].
Nikolić V; Zivanović L; Banićević B; Milosević-Jovcić N
Bilt Hematol Transfuz; 1980; 8(1):19-27. PubMed ID: 7337679
[TBL] [Abstract][Full Text] [Related]
10. Significance of circulating immune complexes in pulmonary tuberculosis.
Samuel AM; Ashtekar MD; Ganatra RD
Clin Exp Immunol; 1984 Nov; 58(2):317-24. PubMed ID: 6437714
[TBL] [Abstract][Full Text] [Related]
11. Circulating immune complexes, complement and complement component levels in childhood Hodgkin's disease.
Brandeis WE; Tan C; Wang Y; Good RA; Day NK
Clin Exp Immunol; 1980 Mar; 39(3):551-61. PubMed ID: 7379328
[TBL] [Abstract][Full Text] [Related]
12. Characterization of mycobacterial antigens and antibodies in circulating immune complexes from pulmonary tuberculosis.
Raja A; Narayanan PR; Mathew R; Prabhakar R
J Lab Clin Med; 1995 May; 125(5):581-7. PubMed ID: 7738424
[TBL] [Abstract][Full Text] [Related]
13. Quantification of polyethylene glycol precipitable circulating immune complex from carcinoma of cervix patients.
Das S
Arch Geschwulstforsch; 1987; 57(4):283-6. PubMed ID: 3675140
[TBL] [Abstract][Full Text] [Related]
14. Presence of circulating immune complexes in patients with chronic lymphocytic leukaemia. Correlations between clinical and immunological features.
Mozzana R; Baldini L; Neri A; Cortelezzi A; Radaelli F; Colajori E; Polli EE
Boll Ist Sieroter Milan; 1982; 61(4):324-9. PubMed ID: 6927220
[TBL] [Abstract][Full Text] [Related]
15. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
[TBL] [Abstract][Full Text] [Related]
16. [Appearance of circulating immune complexes in patients with Hodgkin's disease and the etiology of this disease].
Dziewulska-Bokiniec A; Sztaba-Kania M
Wiad Lek; 1992 Oct; 45(19-20):740-3. PubMed ID: 1296377
[TBL] [Abstract][Full Text] [Related]
17. Changes of circulating immune complexes in the serum and CSF of patients with multiple sclerosis.
Cojocaru M; Cojocaru MI; Steriu O; Băldescu R
Rom J Intern Med; 1992; 30(1):51-6. PubMed ID: 1496259
[TBL] [Abstract][Full Text] [Related]
18. Characterization of ferritin from spleens of patients with Hodgkin's disease (HD).
Nerurkar AV; Vaidya NR; Advani SH; Gothoskar BP
Neoplasma; 1993; 40(1):31-4. PubMed ID: 8350946
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of two antigen nonspecific assays for circulating immune complexes using a model system.
Rodrick M; Rayner A; Steele G; Harte P; Finn D; Verhave M; Munroe A; Zamcheck N; Wilson R
J Clin Lab Immunol; 1982 Apr; 7(3):193-8. PubMed ID: 6178827
[TBL] [Abstract][Full Text] [Related]
20. [Composition of circulating immune complexes in acute toxoplasmosis].
Gladkova SV; Bormotov NI; Dedkova LM; Belanov EF; Golubiatnikova AV; Kiseleva ZF; Reshetnikov SS
Med Parazitol (Mosk); 2000; (4):15-8. PubMed ID: 11210407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
